<DOC>
	<DOCNO>NCT01147588</DOCNO>
	<brief_summary>The aim study determine pharmacological interaction clopidogrel different type proton pump inhibitor ( PPIs ) , extent possible interaction would change time .</brief_summary>
	<brief_title>Study Evaluating Effect Esomeprazole , Omeprazole Lansoprazole Pharmacodynamics ( PD ) Pharmacokinetics ( PK ) Clopidogrel</brief_title>
	<detailed_description />
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Healthy male within age 1845 year females within age 1855 year suitable vein cannulation repeat vein puncture . Females must nonchildbearing potential . Weight 5095kg , inclusive , BMI 1930 kg/m2 , inclusive . No clinically significant abnormal finding judge Investigator enrollment physical exam . History clinically significant disease disorder , opinion investigator , may either put volunteer risk participation study , influence result volunteer 's ability participate study . History presence gastrointestinal e.g . GI ulcer , hepatic renal disease condition know interfere absorption , distribution , metabolism excretion drug . Any clinically significant illness within 4 week first administration investigational product . Any medical/surgical procedure trauma within 3 month treatment period ; schedule surgery , include dental surgery within 2 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>open label</keyword>
	<keyword>randomize</keyword>
	<keyword>4-treatment</keyword>
	<keyword>3-period</keyword>
	<keyword>crossover</keyword>
	<keyword>interaction study</keyword>
	<keyword>Safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>pharmacodynamics</keyword>
</DOC>